narrower midline angle (MLA) (24.78 ± 8.39 vs 55.32 ± 24.84, p <0.001), shorter head-symphisis distance (HSD) (15.11 ± 4.78 vs 18.99 ± 6.67, p 0.028) and wider delta-angle of progression (difference between the AoP at rest and the acme of the pushing effort) (24.28 + 11.92 vs 16.34 + 8.50, p 0.036). At multivariable regression analysis MLA was the only independent predictor of the mode of delivery (p 0.009). Below a MLA of 34.6 degrees the residual chance of OI was 41.7%.
Objectives: Trial of labour after previous Caesarean delivery (TOLAC) may result in adverse outcomes such as uterine rupture.
Although not proved, a 2mm cut-off of the lower uterine segment thickness (LUST) is often used when counselling pregnant women regarding TOLAC. The aim of our study was to establish the normal range of LUST in parturients with no previous Caesarean delivery (CD). Methods: A prospective study of patients between 37 and 41 weeks of gestation with no past CD. All of the women had singleton gestations in the cephalic presentation, an epidural anesthesia and a urinary catheter. Measurements were performed using Samsung's Medison Sonoace R5/R7 ultrasound device. Sonographic evaluation included fetal presentation and attitude, fetal biometry, placental location and myometrial thickness. LUST was measured within 2cm distance above the end an empty bladder while the women experience no contractions. Multiple measures were taken by up to three different experienced sonographers. Results: A total of 64 women were recruited, of which 62 had satisfactory measurements. A total of 28 (45.2%) women were nuliparous and 34 (54.8%) multiparous, 35 (56.4%) were in latent phase while 27 (43.6%) were in active labour (defined as 5cm dilation or more). Of those in active labour, 10 (37%) women were fully dilated when examined. Mean LUST was 3.2±0.8mm (ranging 6.1-1.7mm). No correlation was found between the dilation and mean LUST. Nuliparous women had significant lower mean LUST when compared with multiparous at all stages of labour. Conclusions: We have found that LUST ranges from 1.7 to 6.1mm during delivery with mean LUST of 3.2mm. Further studies are required to estimate the exact risk for uterine rupture according to lower uterine segment.
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Associations of ''endothelial dysfunction'' genes polymorphism in pregnancy-induced hypertension among Uzbek women: a case-control study
U. Ashurova
Republican Specialised Scientific-Practical Medical Centre of Obstetrics and Gynecology, Tashkent, Uzbekistan
Objectives Examine genetic polymorphisms associated with the risk of pregnancy-induced hypertension among Uzbek women. Methods: A total of 78 cases of pre-eclampsia (PE) patients and 26 healthy pregnant female controls were recruited from the Republican Specialised Scientific and Practical Medical Centre of Ob&Gyn in Uzbekistan. Polymorphisms of 5 genes responsible for «endothelial dysfunction» were examined in this study: endothelial nitric oxide synthase NOS3: -786T>C (rs2070744) and 894 G>T (rs1799983); aldosterone synthase CYP11B2 C-344T (rs1799998); angiotensin II receptor type 1 AGTR1 (rs5186) and guanine-binding protein GNB3 C825T (rs5443). Results: There was disequilibrium on Hardy-Weinberg's test in 2 polymorphism (rs1799983) and rs5443 among estimated 5 polymorphism only in control group. Distribution of allele frequencies of genotypes for polymorphism rs1799983, rs1799998, rs5443 genes in PE and in control group revealed presence of risk and protective markers for this disease. Thus, the relative risk of the G allele and GG genotype polymorphism rs1799983 amounted to 2,55 and 4,34; while T allele of the polymorphism can be regarded as a protective marker in the development of this pathology. There was a significant increase in the frequency of mutant allele T polymorphism rs1799998 gene of aldosterone synthase in PE women compared to controls. Frequencies of allele and genotype polymorphisms of rs2070744, rs5186 and rs5443 statistically have no difference in this study. Comparison of haplotype frequencies of polymorphisms rs2070744 and rs1799983 between patients with PE and the control group showed a risky haplotype TG and the protective haplotype CT. For other haplotypes statistically significant differences were not found. Conclusions: Genetic associations performed in this study may be used as genetic markers of PE susceptibility. It can allow to group risk patients, to work out preventive measures. But, the large studies or meta-analysis are required to confirm these findings.
